viewRhinomed Ltd

Rhinomed Limited to update on first stage of global pharmacy distribution


Rhinomed Limited (ASX:RNO) has been granted an ASX trading halt in relation to the first stage in global pharmacy distribution.

The halt will last until the earlier of the announcement being made or the start of trade on Friday, 21st August 2015.

In the June 2015 Quarter, the company reported receipts from customers of $192,000, an increase of $33,000 from the previous quarter due to growing demand for its Turbine sports breathing device.

Sales in FY2016 are expected to increase due to expanded global distribution of Turbine. It has also received early demand for its Mute snoring and sleep technology.

Rhinomed had $1.37 million in cash as at 30th June 2015.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Rhinomed Ltd

Price: 0.076 AUD

Market: ASX
Market Cap: $12.86 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Arizona Silver Exploration will be going back to Philadelphia after drilling...

Arizona Silver Exploration (TSXV: AZS) (OTCQB: AZASF) VP of Exploration Greg Hahn joined Steve Darling from Proactive with some results from the company’s drill program at their Philadelphia project. Hahn discusses the next step the company is planning. Hahn also told Proactive they are...

10 hours, 23 minutes ago

2 min read